
As consumers increasingly prioritize both efficacy and skin barrier safety, the personal care industry is actively shifting away from harsh biocides. Formulators urgently seek mild yet highly effective antimicrobial solutions. The market demands an active ingredient that can precisely target specific pathogens—such as Propionibacterium acnes (acne-causing bacteria) and Malassezia (dandruff-causing fungi)—without causing irritation, while maintaining high stability across complex cosmetic matrices.
Boweixin Biotech’s regulatory affairs (RA) team provides extensive filing support to streamline your approvals